Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-23719

Single-particle
3.9 Å
EMD-23719
3D View Gallery
Deposition: 30/03/2021
Map released: 10/11/2021
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-23719
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7m8l summary report (pdf.gz) Map and 7m8l FULL report (pdf.gz)
EMICSS annotations (xml)

EBOV GP bound to rEBOV-442 and rEBOV-515 Fabs

EMD-23719

Single-particle
3.9 Å
EMD-23719
3D View Gallery
Deposition: 30/03/2021
Map released: 10/11/2021
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Ebola virus
Sample: Complex of mucin deleted Ebola virus GP (Makona variant) bound to rEBOV-442 and rEBOV-515 Fabs
Fitted models: 7m8l

Deposition Authors: Murin CD, Ward AB
Pan-ebolavirus protective therapy by two multifunctional human antibodies.
Gilchuk P, Murin CD, Cross RW, Ilinykh PA, Huang K, Kuzmina N, Borisevich V, Agans KN, Geisbert JB, Zost SJ, Nargi RS, Sutton RE, Suryadevara N, Bombardi RG, Carnahan RH, Bukreyev A, Geisbert TW, Ward AB, Crowe Jr JE
(2021) Cell , 184 , 5593 - 5607.e18
PUBMED: 34715022
DOI: doi:10.1016/j.cell.2021.09.035
ISSN: 1097-4172